Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels
- 31 March 2008
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 210 (1), 164-171
- https://doi.org/10.1016/j.expneurol.2007.10.009
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Cytotoxic lesions of the hippocampus do not impair social recognition memory in socially housed ratsNeurobiology of Learning and Memory, 2006
- Stage-dependent BDNF serum concentrations in Alzheimer’s diseaseJournal of Neural Transmission, 2005
- Serotoninergic Polymorphisms (5-HTTLPRand5-HT2A): Association Studies with Psychosis in Alzheimer DiseaseGenetic Testing, 2003
- Hippocampal Injections of Amyloid β-Peptide 1-40 Impair Subsequent One-Trial/Day Reward LearningNeurobiology of Learning and Memory, 2001
- Progressive brain dysfunction following intracerebroventricular infusion of beta1–42-amyloid peptideBrain Research, 2001
- β-Amyloid(1-42)-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral CortexNeurobiology of Disease, 2001
- Nontoxic Amyloid β Peptide1-42 Suppresses Acetylcholine SynthesisPublished by Elsevier BV ,1997
- β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal OutgrowthExperimental Neurology, 1993
- Loss of brain 5-HT2receptors in Alzheimer's diseaseBrain, 1993
- Social memory deficits in adult male rats exposed to cadmium in infancyNeurotoxicology and Teratology, 1988